Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dihydrocapsaicin is a naturally occurring capsaicinoid, structurally related to capsaicin, and is found in chili peppers of the genus Capsicum. It is a lipophilic, colorless to waxy solid that is odorless and one of the main contributors to the pungency of chili peppers. Dihydrocapsaicin exhibits several pharmacological effects, including anti-inflammatory, anti-microbial, anti-oxidant, and anti-cancer activities[1][2][5][6][7]. Mechanistically, dihydrocapsaicin acts as an agonist of the transient receptor potential vanilloid 1 (TRPV1) receptor on sensory neurons, leading to pain, burning sensation, local desensitization, and neuropeptide depletion similarly to capsaicin[3][5]. Additionally, it has been shown to inhibit cancer cell proliferation and metastasis, notably in melanoma, via downregulating β-catenin and its downstream targets (cyclin D1, c-Myc, MMP2, MMP7), modulating ubiquitination pathways, suppressing NF-κB activity, and reducing oxidative stress and inflammation[1][2][6]. Experimental studies indicate dihydrocapsaicin can protect the blood-brain barrier and reduce ischemic injury by upregulating antioxidant enzymes and inhibiting pro-inflammatory mediators[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dihydrocapsaicin.